Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer

by To, Kenneth K W, Poon, Daniel C, Wei, Yuming, Wang, Fang, Lin, Ge, Fu, Liwu
Published in Br J Pharmacol (2015)

Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer

by To, Kenneth K.W., Poon, Daniel C., Wei, Yuming, Wang, Fang, Lin, Ge, Fu, Li-wu
Published in Data Brief (2016)

A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors

by Wei, Yuming, Poon, Daniel C., Fei, Rong, Lam, Amy S. M., Au-Yeung, Steve C. F., To, Kenneth K. W.
Published in Sci Rep (2016)